Lexicon Pharmaceuticals Reports 3rd Quarter Financial Results And Discusses Collaboration With Sanofi For Sotagliflozin
Go back to Lexicon Pharmaceuticals Reports 3rd Quarter Financial Results And Discusses Collaboration With Sanofi For Sotagliflozin| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 2.15 +0.14 (6.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.01 | 52 Week High | $19.62 | |||
| Open | $1.99 | 52 Week Low | $7.65 | |||
| Day High | $2.15 | P/E | N/A | |||
| Day Low | $1.99 | EPS | $-0.22 | |||
| Volume | 3,026,227 | |||||
